0
0
12/29/23 at 11:30am
Organization
Forbes
Author
Alex Knapp
33 words
0
Comments
2023 saw big shifts in the macroeconomics of the biotech sector, but also major technological milestones for longer, healthier lives.
You are the first to view
https://www.forbes.com/sites/alexknapp/2023/12/29/gene-editing-obesity-drugs-and-long-living-dogs-the-year-in-biotech/
Create an account
or login to join the discussion